nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—SLC28A3—digestive system—systemic scleroderma	0.00777	0.109	CbGeAlD
Fludarabine—SLC28A3—lung—systemic scleroderma	0.00649	0.0913	CbGeAlD
Fludarabine—RRM1—smooth muscle tissue—systemic scleroderma	0.00549	0.0772	CbGeAlD
Fludarabine—RRM1—skin of body—systemic scleroderma	0.00542	0.0762	CbGeAlD
Fludarabine—POLA1—tendon—systemic scleroderma	0.00519	0.0731	CbGeAlD
Fludarabine—SLC29A1—connective tissue—systemic scleroderma	0.00488	0.0686	CbGeAlD
Fludarabine—POLA1—lung—systemic scleroderma	0.00456	0.0642	CbGeAlD
Fludarabine—RRM1—digestive system—systemic scleroderma	0.00433	0.061	CbGeAlD
Fludarabine—RRM1—tendon—systemic scleroderma	0.00412	0.058	CbGeAlD
Fludarabine—DCK—Desoximetasone—Mometasone—systemic scleroderma	0.00373	0.328	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Mometasone—systemic scleroderma	0.00362	0.319	CbGdCrCtD
Fludarabine—RRM1—lung—systemic scleroderma	0.00362	0.0509	CbGeAlD
Fludarabine—SLC29A1—digestive system—systemic scleroderma	0.00352	0.0496	CbGeAlD
Fludarabine—DCK—digestive system—systemic scleroderma	0.00337	0.0474	CbGeAlD
Fludarabine—SLC29A1—tendon—systemic scleroderma	0.00335	0.0472	CbGeAlD
Fludarabine—DCK—tendon—systemic scleroderma	0.0032	0.0451	CbGeAlD
Fludarabine—SLC29A1—lung—systemic scleroderma	0.00294	0.0414	CbGeAlD
Fludarabine—DCK—lung—systemic scleroderma	0.00281	0.0396	CbGeAlD
Fludarabine—DCK—Desoximetasone—Prednisone—systemic scleroderma	0.00204	0.179	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisone—systemic scleroderma	0.00198	0.174	CbGdCrCtD
Fludarabine—Anaemia—Lisinopril—systemic scleroderma	0.000838	0.000913	CcSEcCtD
Fludarabine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000832	0.000907	CcSEcCtD
Fludarabine—Hepatic failure—Methotrexate—systemic scleroderma	0.000831	0.000906	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00083	0.000905	CcSEcCtD
Fludarabine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000828	0.000902	CcSEcCtD
Fludarabine—Body temperature increased—Captopril—systemic scleroderma	0.000826	0.0009	CcSEcCtD
Fludarabine—Oedema—Mycophenolic acid—systemic scleroderma	0.000821	0.000895	CcSEcCtD
Fludarabine—Anorexia—Leflunomide—systemic scleroderma	0.00082	0.000894	CcSEcCtD
Fludarabine—Nausea—Pentoxifylline—systemic scleroderma	0.000819	0.000892	CcSEcCtD
Fludarabine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000818	0.000892	CcSEcCtD
Fludarabine—Malaise—Lisinopril—systemic scleroderma	0.000817	0.000891	CcSEcCtD
Fludarabine—Infection—Mycophenolic acid—systemic scleroderma	0.000816	0.000889	CcSEcCtD
Fludarabine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000815	0.000888	CcSEcCtD
Fludarabine—Diarrhoea—Mometasone—systemic scleroderma	0.000814	0.000887	CcSEcCtD
Fludarabine—Leukopenia—Lisinopril—systemic scleroderma	0.000811	0.000884	CcSEcCtD
Fludarabine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000806	0.000878	CcSEcCtD
Fludarabine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000805	0.000878	CcSEcCtD
Fludarabine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000804	0.000876	CcSEcCtD
Fludarabine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000794	0.000865	CcSEcCtD
Fludarabine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000794	0.000865	CcSEcCtD
Fludarabine—Cough—Lisinopril—systemic scleroderma	0.000791	0.000862	CcSEcCtD
Fludarabine—Visual disturbance—Methotrexate—systemic scleroderma	0.000788	0.000859	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000787	0.000858	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000784	0.000855	CcSEcCtD
Fludarabine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000783	0.000853	CcSEcCtD
Fludarabine—Paraesthesia—Leflunomide—systemic scleroderma	0.000773	0.000842	CcSEcCtD
Fludarabine—Arthralgia—Lisinopril—systemic scleroderma	0.000771	0.000841	CcSEcCtD
Fludarabine—Myalgia—Lisinopril—systemic scleroderma	0.000771	0.000841	CcSEcCtD
Fludarabine—Dyspnoea—Leflunomide—systemic scleroderma	0.000767	0.000836	CcSEcCtD
Fludarabine—Discomfort—Lisinopril—systemic scleroderma	0.000762	0.000831	CcSEcCtD
Fludarabine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000762	0.000831	CcSEcCtD
Fludarabine—Dyspepsia—Leflunomide—systemic scleroderma	0.000758	0.000826	CcSEcCtD
Fludarabine—Vomiting—Mometasone—systemic scleroderma	0.000756	0.000824	CcSEcCtD
Fludarabine—Sweating increased—Prednisone—systemic scleroderma	0.000752	0.00082	CcSEcCtD
Fludarabine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000751	0.000819	CcSEcCtD
Fludarabine—Rash—Mometasone—systemic scleroderma	0.00075	0.000817	CcSEcCtD
Fludarabine—Asthenia—Captopril—systemic scleroderma	0.000749	0.000817	CcSEcCtD
Fludarabine—Dermatitis—Mometasone—systemic scleroderma	0.000749	0.000816	CcSEcCtD
Fludarabine—Decreased appetite—Leflunomide—systemic scleroderma	0.000748	0.000815	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000748	0.000815	CcSEcCtD
Fludarabine—Confusional state—Lisinopril—systemic scleroderma	0.000746	0.000813	CcSEcCtD
Fludarabine—Headache—Mometasone—systemic scleroderma	0.000745	0.000812	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000743	0.00081	CcSEcCtD
Fludarabine—Fatigue—Leflunomide—systemic scleroderma	0.000742	0.000809	CcSEcCtD
Fludarabine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00074	0.000806	CcSEcCtD
Fludarabine—Oedema—Lisinopril—systemic scleroderma	0.00074	0.000806	CcSEcCtD
Fludarabine—Pruritus—Captopril—systemic scleroderma	0.000739	0.000805	CcSEcCtD
Fludarabine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000737	0.000804	CcSEcCtD
Fludarabine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000737	0.000803	CcSEcCtD
Fludarabine—Pain—Leflunomide—systemic scleroderma	0.000736	0.000802	CcSEcCtD
Fludarabine—Constipation—Leflunomide—systemic scleroderma	0.000736	0.000802	CcSEcCtD
Fludarabine—Infection—Lisinopril—systemic scleroderma	0.000735	0.000801	CcSEcCtD
Fludarabine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000734	0.0008	CcSEcCtD
Fludarabine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000732	0.000798	CcSEcCtD
Fludarabine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00073	0.000795	CcSEcCtD
Fludarabine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000724	0.000789	CcSEcCtD
Fludarabine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000723	0.000788	CcSEcCtD
Fludarabine—Neutropenia—Prednisone—systemic scleroderma	0.000722	0.000787	CcSEcCtD
Fludarabine—Body temperature increased—Azathioprine—systemic scleroderma	0.00072	0.000785	CcSEcCtD
Fludarabine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000716	0.00078	CcSEcCtD
Fludarabine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000715	0.000779	CcSEcCtD
Fludarabine—Diarrhoea—Captopril—systemic scleroderma	0.000715	0.000779	CcSEcCtD
Fludarabine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000714	0.000778	CcSEcCtD
Fludarabine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000711	0.000775	CcSEcCtD
Fludarabine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000709	0.000773	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000709	0.000773	CcSEcCtD
Fludarabine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000708	0.000771	CcSEcCtD
Fludarabine—Nausea—Mometasone—systemic scleroderma	0.000706	0.00077	CcSEcCtD
Fludarabine—Anorexia—Lisinopril—systemic scleroderma	0.000705	0.000768	CcSEcCtD
Fludarabine—Pain—Mycophenolic acid—systemic scleroderma	0.000702	0.000765	CcSEcCtD
Fludarabine—Constipation—Mycophenolic acid—systemic scleroderma	0.000702	0.000765	CcSEcCtD
Fludarabine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000697	0.000759	CcSEcCtD
Fludarabine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000693	0.000755	CcSEcCtD
Fludarabine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00069	0.000751	CcSEcCtD
Fludarabine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000688	0.00075	CcSEcCtD
Fludarabine—Body temperature increased—Leflunomide—systemic scleroderma	0.00068	0.000742	CcSEcCtD
Fludarabine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000679	0.00074	CcSEcCtD
Fludarabine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000677	0.000737	CcSEcCtD
Fludarabine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000676	0.000737	CcSEcCtD
Fludarabine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000676	0.000737	CcSEcCtD
Fludarabine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000675	0.000736	CcSEcCtD
Fludarabine—Myocardial infarction—Prednisone—systemic scleroderma	0.000675	0.000736	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000674	0.000734	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000673	0.000733	CcSEcCtD
Fludarabine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000671	0.000732	CcSEcCtD
Fludarabine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000668	0.000728	CcSEcCtD
Fludarabine—Paraesthesia—Lisinopril—systemic scleroderma	0.000664	0.000724	CcSEcCtD
Fludarabine—Vomiting—Captopril—systemic scleroderma	0.000664	0.000724	CcSEcCtD
Fludarabine—Dyspnoea—Lisinopril—systemic scleroderma	0.000659	0.000719	CcSEcCtD
Fludarabine—Rash—Captopril—systemic scleroderma	0.000658	0.000718	CcSEcCtD
Fludarabine—Dermatitis—Captopril—systemic scleroderma	0.000658	0.000717	CcSEcCtD
Fludarabine—Headache—Captopril—systemic scleroderma	0.000654	0.000713	CcSEcCtD
Fludarabine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000653	0.000712	CcSEcCtD
Fludarabine—Dyspepsia—Lisinopril—systemic scleroderma	0.000651	0.000709	CcSEcCtD
Fludarabine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000649	0.000707	CcSEcCtD
Fludarabine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000648	0.000706	CcSEcCtD
Fludarabine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000648	0.000706	CcSEcCtD
Fludarabine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000644	0.000702	CcSEcCtD
Fludarabine—Decreased appetite—Lisinopril—systemic scleroderma	0.000643	0.000701	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000638	0.000696	CcSEcCtD
Fludarabine—Fatigue—Lisinopril—systemic scleroderma	0.000638	0.000695	CcSEcCtD
Fludarabine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000635	0.000693	CcSEcCtD
Fludarabine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000634	0.000691	CcSEcCtD
Fludarabine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000634	0.000691	CcSEcCtD
Fludarabine—Pain—Lisinopril—systemic scleroderma	0.000632	0.000689	CcSEcCtD
Fludarabine—Constipation—Lisinopril—systemic scleroderma	0.000632	0.000689	CcSEcCtD
Fludarabine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000626	0.000683	CcSEcCtD
Fludarabine—Diarrhoea—Azathioprine—systemic scleroderma	0.000624	0.00068	CcSEcCtD
Fludarabine—Haemoglobin—Prednisone—systemic scleroderma	0.000621	0.000677	CcSEcCtD
Fludarabine—Nausea—Captopril—systemic scleroderma	0.00062	0.000676	CcSEcCtD
Fludarabine—Haemorrhage—Prednisone—systemic scleroderma	0.000618	0.000674	CcSEcCtD
Fludarabine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000618	0.000673	CcSEcCtD
Fludarabine—Asthenia—Leflunomide—systemic scleroderma	0.000618	0.000673	CcSEcCtD
Fludarabine—Pancytopenia—Methotrexate—systemic scleroderma	0.000613	0.000668	CcSEcCtD
Fludarabine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000609	0.000664	CcSEcCtD
Fludarabine—Pruritus—Leflunomide—systemic scleroderma	0.000609	0.000664	CcSEcCtD
Fludarabine—Neutropenia—Methotrexate—systemic scleroderma	0.000604	0.000658	CcSEcCtD
Fludarabine—Dysuria—Methotrexate—systemic scleroderma	0.000604	0.000658	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.0006	0.000654	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00059	0.000643	CcSEcCtD
Fludarabine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000589	0.000642	CcSEcCtD
Fludarabine—Diarrhoea—Leflunomide—systemic scleroderma	0.000589	0.000642	CcSEcCtD
Fludarabine—Body temperature increased—Lisinopril—systemic scleroderma	0.000585	0.000637	CcSEcCtD
Fludarabine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000582	0.000634	CcSEcCtD
Fludarabine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000581	0.000633	CcSEcCtD
Fludarabine—Vomiting—Azathioprine—systemic scleroderma	0.000579	0.000632	CcSEcCtD
Fludarabine—Pneumonia—Methotrexate—systemic scleroderma	0.000579	0.000631	CcSEcCtD
Fludarabine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000578	0.00063	CcSEcCtD
Fludarabine—Rash—Azathioprine—systemic scleroderma	0.000575	0.000626	CcSEcCtD
Fludarabine—Dermatitis—Azathioprine—systemic scleroderma	0.000574	0.000626	CcSEcCtD
Fludarabine—Headache—Azathioprine—systemic scleroderma	0.000571	0.000622	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000571	0.000622	CcSEcCtD
Fludarabine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00057	0.000622	CcSEcCtD
Fludarabine—Renal failure—Methotrexate—systemic scleroderma	0.000566	0.000617	CcSEcCtD
Fludarabine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000563	0.000614	CcSEcCtD
Fludarabine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000562	0.000612	CcSEcCtD
Fludarabine—Stomatitis—Methotrexate—systemic scleroderma	0.000561	0.000611	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000559	0.00061	CcSEcCtD
Fludarabine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000554	0.000604	CcSEcCtD
Fludarabine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000554	0.000604	CcSEcCtD
Fludarabine—Arrhythmia—Prednisone—systemic scleroderma	0.000552	0.000602	CcSEcCtD
Fludarabine—Haematuria—Methotrexate—systemic scleroderma	0.000549	0.000598	CcSEcCtD
Fludarabine—Vomiting—Leflunomide—systemic scleroderma	0.000547	0.000596	CcSEcCtD
Fludarabine—Alopecia—Prednisone—systemic scleroderma	0.000546	0.000595	CcSEcCtD
Fludarabine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000545	0.000594	CcSEcCtD
Fludarabine—Epistaxis—Methotrexate—systemic scleroderma	0.000543	0.000592	CcSEcCtD
Fludarabine—Rash—Leflunomide—systemic scleroderma	0.000543	0.000591	CcSEcCtD
Fludarabine—Dermatitis—Leflunomide—systemic scleroderma	0.000542	0.000591	CcSEcCtD
Fludarabine—Nausea—Azathioprine—systemic scleroderma	0.000541	0.00059	CcSEcCtD
Fludarabine—Headache—Leflunomide—systemic scleroderma	0.000539	0.000588	CcSEcCtD
Fludarabine—Malnutrition—Prednisone—systemic scleroderma	0.000538	0.000587	CcSEcCtD
Fludarabine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000534	0.000582	CcSEcCtD
Fludarabine—Asthenia—Lisinopril—systemic scleroderma	0.000531	0.000578	CcSEcCtD
Fludarabine—Pruritus—Lisinopril—systemic scleroderma	0.000523	0.00057	CcSEcCtD
Fludarabine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000522	0.000569	CcSEcCtD
Fludarabine—Haemoglobin—Methotrexate—systemic scleroderma	0.000519	0.000566	CcSEcCtD
Fludarabine—Rash—Mycophenolic acid—systemic scleroderma	0.000518	0.000564	CcSEcCtD
Fludarabine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000517	0.000564	CcSEcCtD
Fludarabine—Haemorrhage—Methotrexate—systemic scleroderma	0.000517	0.000563	CcSEcCtD
Fludarabine—Headache—Mycophenolic acid—systemic scleroderma	0.000514	0.000561	CcSEcCtD
Fludarabine—Pharyngitis—Methotrexate—systemic scleroderma	0.000513	0.000559	CcSEcCtD
Fludarabine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000512	0.000558	CcSEcCtD
Fludarabine—Nausea—Leflunomide—systemic scleroderma	0.000511	0.000557	CcSEcCtD
Fludarabine—Diarrhoea—Lisinopril—systemic scleroderma	0.000506	0.000551	CcSEcCtD
Fludarabine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000499	0.000544	CcSEcCtD
Fludarabine—Visual impairment—Methotrexate—systemic scleroderma	0.000498	0.000543	CcSEcCtD
Fludarabine—Anaemia—Prednisone—systemic scleroderma	0.000497	0.000542	CcSEcCtD
Fludarabine—Agitation—Prednisone—systemic scleroderma	0.000495	0.000539	CcSEcCtD
Fludarabine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000489	0.000532	CcSEcCtD
Fludarabine—Nausea—Mycophenolic acid—systemic scleroderma	0.000488	0.000532	CcSEcCtD
Fludarabine—Malaise—Prednisone—systemic scleroderma	0.000485	0.000529	CcSEcCtD
Fludarabine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00052	CcSEcCtD
Fludarabine—Vomiting—Lisinopril—systemic scleroderma	0.00047	0.000512	CcSEcCtD
Fludarabine—Rash—Lisinopril—systemic scleroderma	0.000466	0.000508	CcSEcCtD
Fludarabine—Convulsion—Prednisone—systemic scleroderma	0.000466	0.000508	CcSEcCtD
Fludarabine—Dermatitis—Lisinopril—systemic scleroderma	0.000466	0.000508	CcSEcCtD
Fludarabine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000465	0.000507	CcSEcCtD
Fludarabine—Chills—Methotrexate—systemic scleroderma	0.000464	0.000505	CcSEcCtD
Fludarabine—Headache—Lisinopril—systemic scleroderma	0.000463	0.000505	CcSEcCtD
Fludarabine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000458	0.0005	CcSEcCtD
Fludarabine—Myalgia—Prednisone—systemic scleroderma	0.000458	0.000499	CcSEcCtD
Fludarabine—Arthralgia—Prednisone—systemic scleroderma	0.000458	0.000499	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—systemic scleroderma	0.000457	0.000498	CcSEcCtD
Fludarabine—Discomfort—Prednisone—systemic scleroderma	0.000453	0.000493	CcSEcCtD
Fludarabine—Malnutrition—Methotrexate—systemic scleroderma	0.00045	0.00049	CcSEcCtD
Fludarabine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000443	0.000483	CcSEcCtD
Fludarabine—Nausea—Lisinopril—systemic scleroderma	0.000439	0.000479	CcSEcCtD
Fludarabine—Oedema—Prednisone—systemic scleroderma	0.000439	0.000479	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000439	0.000479	CcSEcCtD
Fludarabine—Infection—Prednisone—systemic scleroderma	0.000436	0.000476	CcSEcCtD
Fludarabine—Nervous system disorder—Prednisone—systemic scleroderma	0.000431	0.000469	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000425	0.000463	CcSEcCtD
Fludarabine—Anorexia—Prednisone—systemic scleroderma	0.000419	0.000456	CcSEcCtD
Fludarabine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000417	0.000455	CcSEcCtD
Fludarabine—Anaemia—Methotrexate—systemic scleroderma	0.000416	0.000453	CcSEcCtD
Fludarabine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000412	0.000449	CcSEcCtD
Fludarabine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000409	0.000445	CcSEcCtD
Fludarabine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000408	0.000445	CcSEcCtD
Fludarabine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000406	0.000442	CcSEcCtD
Fludarabine—Malaise—Methotrexate—systemic scleroderma	0.000406	0.000442	CcSEcCtD
Fludarabine—Leukopenia—Methotrexate—systemic scleroderma	0.000403	0.000439	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.0004	0.000436	CcSEcCtD
Fludarabine—Paraesthesia—Prednisone—systemic scleroderma	0.000394	0.00043	CcSEcCtD
Fludarabine—Cough—Methotrexate—systemic scleroderma	0.000392	0.000428	CcSEcCtD
Fludarabine—Convulsion—Methotrexate—systemic scleroderma	0.00039	0.000425	CcSEcCtD
Fludarabine—Dyspepsia—Prednisone—systemic scleroderma	0.000387	0.000421	CcSEcCtD
Fludarabine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000385	0.000419	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—systemic scleroderma	0.000383	0.000417	CcSEcCtD
Fludarabine—Arthralgia—Methotrexate—systemic scleroderma	0.000383	0.000417	CcSEcCtD
Fludarabine—Decreased appetite—Prednisone—systemic scleroderma	0.000382	0.000416	CcSEcCtD
Fludarabine—Fatigue—Prednisone—systemic scleroderma	0.000379	0.000413	CcSEcCtD
Fludarabine—Discomfort—Methotrexate—systemic scleroderma	0.000378	0.000412	CcSEcCtD
Fludarabine—Constipation—Prednisone—systemic scleroderma	0.000376	0.000409	CcSEcCtD
Fludarabine—Confusional state—Methotrexate—systemic scleroderma	0.00037	0.000403	CcSEcCtD
Fludarabine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000367	0.0004	CcSEcCtD
Fludarabine—Infection—Methotrexate—systemic scleroderma	0.000365	0.000397	CcSEcCtD
Fludarabine—Feeling abnormal—Prednisone—systemic scleroderma	0.000362	0.000394	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00036	0.000392	CcSEcCtD
Fludarabine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000359	0.000392	CcSEcCtD
Fludarabine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000355	0.000387	CcSEcCtD
Fludarabine—Anorexia—Methotrexate—systemic scleroderma	0.00035	0.000381	CcSEcCtD
Fludarabine—Body temperature increased—Prednisone—systemic scleroderma	0.000347	0.000378	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000334	0.000364	CcSEcCtD
Fludarabine—Paraesthesia—Methotrexate—systemic scleroderma	0.00033	0.000359	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—systemic scleroderma	0.000327	0.000357	CcSEcCtD
Fludarabine—Hypersensitivity—Prednisone—systemic scleroderma	0.000324	0.000353	CcSEcCtD
Fludarabine—Dyspepsia—Methotrexate—systemic scleroderma	0.000323	0.000352	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—systemic scleroderma	0.000319	0.000348	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000317	0.000345	CcSEcCtD
Fludarabine—Fatigue—Methotrexate—systemic scleroderma	0.000316	0.000345	CcSEcCtD
Fludarabine—Asthenia—Prednisone—systemic scleroderma	0.000315	0.000343	CcSEcCtD
Fludarabine—Pain—Methotrexate—systemic scleroderma	0.000314	0.000342	CcSEcCtD
Fludarabine—Pruritus—Prednisone—systemic scleroderma	0.000311	0.000339	CcSEcCtD
Fludarabine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000302	0.00033	CcSEcCtD
Fludarabine—Diarrhoea—Prednisone—systemic scleroderma	0.000301	0.000328	CcSEcCtD
Fludarabine—Body temperature increased—Methotrexate—systemic scleroderma	0.00029	0.000316	CcSEcCtD
Fludarabine—Vomiting—Prednisone—systemic scleroderma	0.000279	0.000304	CcSEcCtD
Fludarabine—Rash—Prednisone—systemic scleroderma	0.000277	0.000302	CcSEcCtD
Fludarabine—Dermatitis—Prednisone—systemic scleroderma	0.000277	0.000302	CcSEcCtD
Fludarabine—Headache—Prednisone—systemic scleroderma	0.000275	0.0003	CcSEcCtD
Fludarabine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00027	0.000295	CcSEcCtD
Fludarabine—Asthenia—Methotrexate—systemic scleroderma	0.000263	0.000287	CcSEcCtD
Fludarabine—Nausea—Prednisone—systemic scleroderma	0.000261	0.000284	CcSEcCtD
Fludarabine—Pruritus—Methotrexate—systemic scleroderma	0.00026	0.000283	CcSEcCtD
Fludarabine—Diarrhoea—Methotrexate—systemic scleroderma	0.000251	0.000274	CcSEcCtD
Fludarabine—Vomiting—Methotrexate—systemic scleroderma	0.000233	0.000254	CcSEcCtD
Fludarabine—Rash—Methotrexate—systemic scleroderma	0.000231	0.000252	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—systemic scleroderma	0.000231	0.000252	CcSEcCtD
Fludarabine—Headache—Methotrexate—systemic scleroderma	0.00023	0.000251	CcSEcCtD
Fludarabine—Nausea—Methotrexate—systemic scleroderma	0.000218	0.000238	CcSEcCtD
